Request a Premium Quote

CDC to Invest $2.1B to Expand Infectious Disease Detection, Prevention Efforts

FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests

Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022

In Brief This Week: Roche, Myriad Genetics, Danaher, and More

UK Opens Consultation on New Diagnostics Regulations

Sebia, Metafora Biosystems Partner to Develop IVD Tests